The results suggest that the RyR1-L3625D mutation removes both an early activating effect of S100A1 and CaM and delayed suppressing effect of CaCaM on RyR1 Ca 2ϩ release, providing new insights into CaM and S100A1 regulation of skeletal muscle excitation-contraction coupling.
Ca
2ϩ release channel; excitation-contraction coupling; Ryr1 D/D mouse; RyR1-L3625D THE SARCOPLASMIC RETICULUM (SR) is an intracellular organelle that plays a key role in striated muscle contraction and relaxation by releasing and resequestering Ca 2ϩ from the myoplasm. A Ca 2ϩ release channel known as the ryanodine receptor (RyR) and an ATP-driven Ca 2ϩ pump are the two principal transport systems responsible for the release and uptake of Ca 2ϩ (7, 8, 18) . In excitation-contraction (EC) coupling of skeletal muscle, an action potential initiates L-type Ca 2ϩ channel (Cav1.1) conformational changes that lead to the activation of the skeletal muscle RyR (RyR1) via a direct interaction, the release of Ca 2ϩ from the SR, and muscle contraction (33) . RyR1 is the major ryanodine receptor isoform in skeletal muscle (12) . Both transcriptional and posttranscriptional mechanisms contribute to the coordinated assembly of the functional Cav1.1-RyR1 complex (31) . RyR1 is a large ion channel composed of four 560-kDa peptide subunits, four 12-kDa FK506 binding proteins, and multiple associated proteins that include calmodulin (CaM) and S100A1. Both the Ca 2ϩ -free (apoCaM) and Ca 2ϩ -bound (CaCaM) forms of CaM bind with nanomolar affinity to RyR1 (2) . CaM activates RyR1 at submicromolar Ca 2ϩ concentrations and inhibits RyR1 at micromolar Ca 2ϩ concentrations. Mutagenesis, peptide studies, and cryo-electron microscopy indicate that apoCaM and CaCaM bind to an overlapping region (amino acid residues 3614 -3643) distal to the ion pore of RyR1 (30, 32, 50) . This suggests that CaM exerts its effects allosterically through long-range interactions within RyR1.
Insights into the cellular regulation of RyR1 by CaM have been obtained by expressing two RyR1 mutants in RyR1-deficient (dyspedic) myotubes (22) . Neither RyR1-L3624D deficient in apoCaM and CaCaM binding nor RyR1-W3620A deficient in only CaCaM binding eliminated voltage-gated SR Ca 2ϩ release. On the other hand, studies with permeabilized adult mouse skeletal myofibers suggested that CaM regulation of RyR1 may have a role in skeletal muscle EC coupling (29) . CaM decreased the frequency and size of Ca 2ϩ sparks, whereas a Ca 2ϩ -insensitive mutant of CaM increased both spark frequency and amplitude. However, the physiological relevance of eliminating the interaction of CaM with RyR1 is unclear.
S100A1 is a member of the S100 Ca 2ϩ binding protein family that regulates SR Ca 2ϩ release and mitochondrial function in many tissues including cardiac and skeletal muscle (11, 46) . S100A1 bound to several RyR1 fragments and activated the receptor at nanomolar Ca 2ϩ concentrations (43) . Competition studies with CaM and binding experiments with an RyR1 fragment (amino acid residues 3616 -3627) (27, 47) revealed that S100A1 binds to the NH 2 -terminal region of the CaM binding domain involved in binding the Ca 2ϩ -bound form of CaM to RyR1 (17, 30, 50) . Intact flexor digitorum brevis (FDB) muscle fibers isolated from S100A1-knockout mice exhibited a decreased Ca 2ϩ transient amplitude during a single action potential and decreased SR Ca 2ϩ release flux in response to voltage-clamp depolarizations (26, 27) . These results suggested that S100A1 potentiates skeletal muscle EC coupling by interacting with the NH 2 -terminal region of the RyR1 CaM binding domain.
To better understand the in vivo role of CaM and S100A1 regulation of RyR1, we prepared a genetic strain of mice by homologous recombination expressing a mutant form of RyR1 (RyR1-L3625D or RyR1 D ). We showed previously that the homologous mutation L3624D in rabbit RyR1 reduces CaM binding affinity and CaM regulation of recombinant RyR1 expressed in human embryonic kidney (HEK) 293 cells (50) . Leu-3625 is located on the hydrophobic side of an amphipathic helix involved in RyR1 binding of both CaCaM and CaS100A1 (17, 47) . In the present study, the physiological effects of impaired regulation of RyR1 by CaM and S100A1 were examined using isolated skeletal muscle membrane and fiber preparations from Ryr1 D/D mice, and by evaluating whole muscle contractility in vivo. The present and previous results indicate that the predominant modulatory effects of S100A1 or CaM binding to this domain of RyR1 in skeletal muscle are 1) a potentiation of SR Ca 2ϩ release by S100A1 during a single action potential or initial depolarization; and 2) a suppression of release by delayed inhibition of SR Ca 2ϩ release by CaCaM during repetitive action potentials or prolonged depolarization. These opposing early activating effects of S100A1 and later inhibitory effects of CaCaM on SR Ca 2ϩ release are both eliminated in the Ryr1 D/D mice. These studies provide insight into how CaM and S100A1 binding to RyR1 tunes SR Ca 2ϩ release to differentially regulate EC coupling.
EXPERIMENTAL PROCEDURES

Materials. [
3 H]ryanodine was obtained from Perkin Elmer Life Sciences, protease and phosphatase inhibitor cocktails from Sigma, and phospholipids from Avanti Polar Lipids. Other chemicals were from Sigma-Aldrich unless specified otherwise.
Preparation of mutant mice. Mouse Ryr1 gene was kindly provided by Dr. Jonathan Stamler (Case Western Reserve University, Cleveland, OH). Multiple base changes in exon 74 that encodes the CaM and S100A1 binding domain were introduced by pfu polymerasebased chain reaction using mutagenic oligoprimers and the QuikChange site-directed mutagenesis kit (Stratagene). A 7.7-kb fragment with the mutation (L3625D, D mutation) and 1.2-kb fragment were cloned into pBR322 containing the neomycin-resistant gene flanked by loxP sites and thymidine kinase gene (Fig. 1) . Mutant mice carrying the RyR1-L3625D mutation (RyR D ) were prepared using established methods (4) . Briefly, linearized targeting vector was transfected into embryonic stem (ES) cells (cell line E14) by electroporation. Cells containing the recombinant gene were selected in presence of G418 and gancyclovir. ES cell clones were screened by PCR and Southern blotting, and mutations were confirmed by sequencing. Targeted ES cells were injected into blastocysts of C57BL/6J mice in the Animal Models Core Facility of University of North Carolina at Chapel Hill. A male chimera mouse carrying the RyR1-L3625D mutation was mated with a 129/SvEv female mouse to obtain heterozygous offspring. Targeting construct also carried the Cre recombinase gene driven by a testis-specific angiotensin-converting enzyme promoter. Therefore, germ line transmission of the mutation to heterozygous offspring caused removal of the gene cassette flanked by loxP sites (5 Preparation of membrane fractions. Leg skeletal muscle was homogenized in 0.02 M imidazole, pH 7.0, 0.3 M sucrose, 0.15 M NaCl, 0.1 mM EGTA, protease inhibitors (Sigma), and 1 mM glutathione (oxidized form), using a Tekmar Tissumizer for 2 ϫ 7 s at a setting of 13,500 rpm. Homogenates were centrifuged for 45 min at 35,000 rpm in a Beckman Ti75 rotor, and pellets were resuspended in the above buffer without EGTA and glutathione to obtain a crude membrane fraction. Membranes were stored in small aliquots at Ϫ80°C.
Single-channel recordings. Single-channel measurements of wildtype (WT) and mutant RyR1s were performed in planar lipid bilayers as described with some modifications (51) . Crude skeletal muscle membrane fractions containing WT and mutant RyR1s were pretreated for 30 min with 1 M myosin light chain kinase-derived CaM binding peptide to facilitate dissociation of endogenous CaM (1). The final peptide concentration was 10 nM after the addition of membranes to the cis, cytosolic chamber of the bilayer apparatus. A strong dependence of single-channel activities on cis Ca 2ϩ concentration indicated that the large cytosolic "foot" region faced the cis chamber of the bilayers. The trans SR luminal side of the bilayer was defined as ground. Measurements were made with symmetrical 0.25 M CsCl, 20 mM CsHepes, pH 7.4, with the indicated concentrations of Ca 2ϩ and ATP. Exogenous CaM and S100A1 were added to the cis, cytosolic solution. Electrical signals were filtered at 2 kHz, digitized at 10 kHz, and analyzed as described (48) . Channel open probabilities (Po) were obtained from 2-min recordings by setting the threshold level at 25% and 50% of the current amplitude between the closed (c) and open (o) channel states. Po values in multichannel recordings were calculated using the equation Po ϭ Α iPo,i/N, where N is the total number of channels and Po,i is channel open probability of the ith channel.
[ 45 Ca 2ϩ uptake rates, aliquots were placed at 2, 4, and 6 min on 0.45-M Millipore filters under vacuum and rinsed with three 3-ml volumes of ice-cold 0.175 M KCl, 5 mM imidazole, pH 7.0. Radioactivity remaining with the vesicles on the filters was determined by liquid scintillation counting.
Isothermal titration calorimetry. Peptide binding to CaS100A1 was examined via isothermal titration calorimetry (ITC), using a VP-ITC titration microcalorimeter (MicroCal, Northhampton, MA; General Electric) as described (27, 47) . For ITC, all S100A1 and peptide solutions were degassed under vacuum for 5 min and equilibrated at 37°C before use. The reference cell contained double-distilled H 2O, and the sample cell (1.4 ml) contained 50 mM HEPES, pH 7.2, 15 mM NaCl, 10 mM CaCl2, and 50 M S100A1. Upon equilibration, a 2 mM (WT) or 5 mM (mutant) peptide solution prepared in the same buffer as above (without S100A1) was injected in 5-l aliquots with a 300-s interval between each injection. Data were fit using ITC software provided by the vendor. S100A1 was prepared as described (27, 47) . Synthetic peptides were purchased from Biosynthesis (Lewisville, TX) with their amino termini acetylated (acϪ) and their COOH termini amidated (Ϫam). Concentrations and composition were confirmed using amino acid analyses. These include the wildtype RyRP12 peptide derived from residues 3617-3628 of RyR1 (ac-KKAVWHKLLSKQ-am) and mutant RyRP12 peptides (ac-KKAVWHKLDSKQ-am; ac-KKAVDHKLLSKQ-am; ac-KKAVD-HKLDSKQ-am); mutations are underlined.
FDB fiber preparation. Fibers were prepared using enzymatic dissociation of FDB muscles of 1.5-mo-old Ryr1 ϩ/ϩ and Ryr1 D/D mice and were cultured as described (13) . After ϳ24 h in minimal essential medium, fiber culture medium was changed to 2 ml Ringer solution (135 mM NaCl, 4 mM KCl, 1 mM MgCl 2, 10 mM HEPES pH 7.4, 10 mM glucose, 1.8 mM CaCl2).
Monitoring single-fiber Ca 2ϩ transients using Indo-1 ratiometric recordings or high-speed confocal microscopy with Fluo-4. FDB fiber loading with Indo-1 AM, ratiometric recording, image sampling, and data analysis were performed as described (27) . Similarly, Fluo-4-AM loading, high-speed linescan x-t imaging on a Zeiss LSM 5 Live confocal system, and image analysis were performed as described (27) . Multiple stimulation paradigms were performed as described in
RESULTS.
Calculation of SR Ca 2ϩ release flux from Fluo-4-AM fluorescence recordings. Fluo-4 fluorescence recordings (F) and baseline fluorescence (F 0) were converted to ratio signals [R ϭ (F Ϫ F0)/F0]. To derive the free Ca 2ϩ concentration according to Eq. 1, we assumed KD,fluo ϭ 1 M which is within the range of estimates for myoplasmic conditions (9) and koff,fluo ϭ 90 s Ϫ1 (37) .
The fluorescence ratio at saturating Ca 2ϩ concentration Rmax was determined for each individual fiber using ionomycin permeabilization (5 M). 
To determine Ca 2ϩ release underlying action potential-induced Fluo-4 fluorescence transients, we used a pulse paradigm consisting of a single stimulus followed (after 400 ms) by five sequential tetani at 100 Hz (200 ms each) applied at intervals of 200 ms. This protocol provides six long relaxation intervals after the single pulse and following the tetani that can be used to characterize Ca 2ϩ removal (19, 20, 42) . After data reduction by averaging every five consecutive sample points, traces were smoothed using an adaptive digital filter (35) . A Ca 2ϩ removal model including binding and transport was used to simultaneously fit the relaxation phases in the long intervals and in the 700-ms recording period following the last tetanus. Binding to Ca 2ϩ -specific sites of troponin C (T-sites) and parvalbumin-like Ca 2ϩ -Mg 2ϩ sites (P-sites) was calculated as described (3) . Binding site concentrations and rate constants of troponin and parvalbumin were adopted from Baylor and Hollingworth (3). The rate constants were adjusted to our experimental temperature of 20°C by linear interpolation of the values at 16°C and 28°C published in that study. Fast Ca 2ϩ binding to ATP was described by a component proportional to free Ca 2ϩ [scaling factor F ϭ 3.6; (3)]. Ca 2ϩ removal by transport (e.g., uptake by the SR Ca 2ϩ -ATPase) was assumed to be proportional to free [Ca 2ϩ ] (rate constant kuptake). The rate constant values used for the calculations were for T-sites: k on,T,Ca ϭ 115 M/s, koff,T,Ca ϭ 150 s Ϫ1 ; and for P-sites: kon,P,Ca ϭ 54.0 M/s, koff,P,Ca ϭ 0.65 s Ϫ1 , k on,P,Mg ϭ 0.043 M/s, koff,P,Mg ϭ 3.9 s Ϫ1 , kuptake ϭ 1,000 s Ϫ1 .
[T]tot and [P]tot, the total concentrations of T-sites and P-sites, were 0.240 mM and 1.5 mM, respectively. After an initial calculation with these parameters, k on,P,Mg and kuptake were adjusted by iteration to minimize the least squares deviation between calculated and measured fluorescence ratio in the six relaxation phases.
The fit started ϳ20 ms after the end of the depolarization to account for the time required to turn off Ca 2ϩ release. The Ca 2ϩ occupancies of all model compartments [T-sites, P-sites, ATP (F-sites) and uptake] were summed, and the release flux was calculated as the time derivative of the sum. Calculations were performed using Euler's method (36) . Analysis software was written in Delphi (Borland) and Visual Basic for Excel (Microsoft).
Ca 2ϩ transient recording and calculation of Ca 2ϩ release flux during pulse depolarization of single voltage-clamped muscle fibers.
All solutions used for single muscle fiber voltage-clamp experiments were identical to those used previously (25) , except for the addition of 50 M Fluo-4 to the internal solution in the patch pipette to monitor Ca 2ϩ transients. Fluorescence signals were recorded during voltageclamp depolarizations using a high-speed confocal system (Zeiss LSM 5 LIVE) synchronized with the patch-clamp system (26) . Ca 2ϩ release flux from voltage clamp-elicited Fluo-4 transients was calculated as described (26) .
Contractile function. As a measure of whole muscle force production, we recorded tension generated by the tibialis anterior (TA) muscle in vivo, as previously described (14) . Briefly, the distal TA tendon of anesthetized animals was surgically released and attached to a load cell. A 26-gauge needle was then inserted through the proximal tibia to stabilize the leg. The load cell was adjusted via a micromanipulator to stretch the muscle to a set resting length (11 mm). TA contraction was then triggered via subcutaneous stimulation of the peroneal nerve, and the resulting force generated was sampled at 1 kHz and analyzed with Polyview acquisition software. We utilized several stimulation protocols, which are detailed in RESULTS, to evaluate force generation. Following contractile function experiments, animals were euthanized and the TAs were isolated and weighed. As muscle length was fixed in all experiments, and muscle density was assumed to be a constant 1.06 mg/mm 3 , physiological cross-sectional area (PCSA ϭ mass/density ϫ length) of the TA was solely a function of muscle mass. Force (F) was therefore normalized to TA mass to calculate specific force, P0 ϭ F/PCSA.
Biochemical assays and data analyses. Free Ca 2ϩ concentrations were obtained by including the appropriate amounts of Ca 2ϩ and EGTA determined using stability constants and a published computer program (34 -bound (CaCaM) forms of CaM (2) . We showed previously that in the presence of 0.1-0.2 and 100 M Ca 2ϩ , the single L3624D substitution in rabbit RyR1 reduced CaM binding affinity and regulation of recombinant RyR1 expressed in HEK 293 cells (50) . In the present study, we generated by homologous recombination a mouse with the corresponding substitution (L3625D) in RyR1 (RyR1 D ) (Fig. 1) . The mutation did not noticeably alter the appearance, general behavior, body weight, or lifespan of the Ryr1 D/D mice, which suggested that the possibility of long-term or nonspecific effects of the mutation in muscle or other tissues was minimal. (Fig. 2A) (Fig. 2) . In the absence of CaM, there were no significant differences in P o between Ryr1 ϩ/ϩ and Ryr1 D/D channels at 0.2 and 7 M cis free Ca 2ϩ (Fig. 2 legend) . Addition of 20 and 200 nM CaM to the cis side of the bilayer increased activity of Ryr1 ϩ/ϩ channels at 0.2 M free Ca , WT but not mutant channels were significantly inhibited by 20 nM CaM (Fig. 2B ). Both types of channels were inhibited by the addition of 200 nM CaM to the cis side of the bilayer.
The effects of the RyR1 D mutation on the interaction of CaM and RyR1 were also examined in a ligand binding assay, using the RyR-specific probe ryanodine (Fig. 3) . [ 3 H]ryanodine (50) , which was consistent with the X-ray structure of a complex between a binding domain peptide of RyR1 and CaCaM (Fig. 4, B and D) . Likewise, based on the nuclear magnetic resonance (NMR)- ajpcell.physiology.org structure of S100A1-RyRP12 (Fig. 4, A and C) , it was not surprising that a 12-residue RyRP12 peptide from this same S100A1/CaM binding domain of the intact RyR1 competed with the full-length RyR1 for binding to CaCaM and CaS100A1 (27, 47, 50) . As with the CaCaM-RyR1 peptide X-ray structure (17), the NMR structure of S100A1-RyRP12 illustrates the importance of the hydrophobic face of the amphipathic RyRP12 peptide for complex formation that include residues W3621 and L3625.
To examine this interaction in more detail, binding of CaS100A1 to WT and mutant RyRP12 peptides derived from RyR1 was measured using ITC. In Fig. 4E , representative ITC traces are shown together with theoretical fitted curves for the binding of WT and three mutant RyRP12 peptides to CaS100A1. For the WT RyRP12 peptide, binding to CaS100A1 was readily detected (n ϭ 0.75 Ϯ 0.12; K D ϭ 75 Ϯ 12 M; ⌬H ϭ Ϫ5.8 Ϯ 0.6 kcal/mol). However, data for the L3625D mutant peptide were barely detectable; specifically, the binding was so weak that the stoichiometry could not be quantitatively determined, so it could only be assumed (n ϭ 1). Therefore, the ITC data for the L3625D mutant provided only a limiting value for binding (K D Ͼ 0.9 Ϯ 0.1 mM). No detectable binding was observed for the W3621D or the W3621D ϩ L3625D double mutant. Together, the data show that the same RyR1 region, which includes W3621 and L3625, is important for binding both CaCaM and CaS100A1.
S100A1 regulation of RyR1 isolated from Ryr1
ϩ/ϩ and Ryr1 D/D mice. Next we probed the effect of the RyR1 D mutation in eliminating the regulation of RyR1 by S100A1. channel recordings at 0.2 M Ca 2ϩ was increased by 145% of the control with 0.3 M S100A1 and by 205% with 1 M S100A1 in the cis chamber (Fig. 5, bottom left) . Addition of 3 M S100A1 did not further increase the activity of WT channels (not shown). Ryr1 D/D channels were not activated by 0.3 and 1 M S100A1 (Fig. 5, bottom right) 3 H]ryanodine binding were observed for 3-mo-old (not significant) and 5.5-mo-old (significant) mice (Fig. 6A) . No significant differences in [ 3 H]ryanodine binding affinity were observed (K D ϭ 12.8 Ϯ 1.3 nM and 17.7 Ϯ 3.2 nM for mutant and WT muscle isolates, respectively, n ϭ 5).
RyR1 is the major ryanodine receptor isoform in skeletal muscle (12) . To determine whether the RyR D mutation increased the mRNA levels of the other two mammalian RyR isoforms RyR2 and RyR3, we used quantitative RT-PCR. The mRNA levels of all three RyR isoforms were increased to a similar extent (1.5-to 2-fold, not significant) in skeletal muscle of Ryr1 D/D mice compared with Ryr1 ϩ/ϩ mice (n ϭ 4). The data suggest that RyR1 remains the predominant ryanodine receptor isoform in the skeletal muscle of the mutant mice. ] i . Following an initial conditioning stimulus, a second stimulus was given after 40, 80, or 160 ms of recovery (Fig.  7C) . When normalized to the amplitude of the first transient elicited by the conditioning stimulus, the peak amplitude of the second Indo-1 transient was significantly increased following 40 ms recovery in Ryr1 D/D fibers compared with their control counterparts (P ϭ 0.023). This summation of the Ca 2ϩ transient in mutant fibers became less pronounced as time allowed for recovery between stimuli increased (Fig. 7C) . ajpcell.physiology.org fibers using an ultra-high-speed (50 s/line) line-scanning confocal microscope. Figure 8A demonstrates average responses from 18 control and 15 mutant fibers stimulated by a single action potential followed by a train of 10 action potentials at 100 Hz. Consistent with the Indo-1 data (Fig. 7) , Ryr1 D/D fibers demonstrated reduced amplitude of the fluorescent Ca 2ϩ transient in response to single and tetanic action potential stimuli. However, when the traces were normalized to the amplitude of the first transient response, it was clear that there was greater relative summation of the Ca 2ϩ transient during repetitive stimulation in the mutant fibers compared with control counterparts (Fig. 8B) . Quantifying this summation as the ratio of the peak amplitude of the last transient to the first, the mutants demonstrated roughly twofold greater summation of Ryr1 ϩ/ϩ fibers ( with internal solution containing 20 mM EGTA and 50 M Fluo-4 in the patch pipette for 20 min, and subjected to 80 ms depolarizing steps at 10-mV increments, starting from a holding potential of Ϫ80 mV. SR Ca 2ϩ release flux was calculated from the resulting ⌬F records in a procedure identical to that described (26) . Consistent with previous reports, release flux at larger depolarizations consisted of a rapid rise to peak followed by a fast inactivation component, followed by a more slowly declining release for the duration of the pulse (Fig. 10A) . As can be seen in the time course of release flux and in the release versus voltage (R vs. V) relationships (Fig. 10A) , peak release flux was suppressed at all test voltages in the mutant fibers. The R-V relationship of control and mutant fibers was fit to a single Boltzmann function (Fig. 10A, right) :
Action potential evoked Indo-1 Ca 2ϩ transients in Ryr1
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with parameters R max (maximum release flux), V half (voltage of half-maximal activation), and k (slope factor). R max ϭ 45.01 Ϯ 1.5 M/ms, V half ϭ Ϫ11.9 Ϯ 1.7 mV, k ϭ 9.4 Ϯ 1.63 mV, for six control fibers, and R max ϭ 26.5 Ϯ 4.3 M/ms, V half ϭ Ϫ15.7 Ϯ 1.4 mV, k ϭ 8.0 Ϯ 1.32 mV, for eight mutant fibers. There was a 41% decrease in R max in mutant Ryr1 D/D fibers (P Ͻ 0.05).
To evaluate the kinetics of release flux, we compared the time course of release for control and mutant Ryr1 D/D fibers at each voltage step, normalized to the peak amplitude of release.
As can be seen in Fig. 10B , during the smaller depolarizations, such as to Ϫ20 mV (left), there were no noticeable differences in the relative time courses of release flux throughout the pulse. However, at larger depolarizations, such as to 0 mV (middle), a noticeable shoulder of sustained release was evident in the mutant To measure function, we recorded maximal isometric contractile force produced by the TA muscles of anesthetized animals. Figure 11A shows representative twitch (single action potential stimulation) and maximal tetanic (100 Hz) force responses from Ryr1 ϩ/ϩ and Ryr1 D/D mice. Onehundred-hertz stimulation was used to elicit peak tetanic force, because greater stimulation frequencies resulted in a submaximal fused tetanus. As quantified in Fig. 11C and Table 1 , mutant mice elicited a significant, 25% decrease in D/D (gray trace; n ϭ 22) fibers. Isolated fibers were stimulated with field electrodes at 400 ms, and emission ratio was examined. B: bar plot summarizing resting Indo-1 ratio averages (left) and peak ⌬Indo-1 ratio (right) of control and mutant fibers. No significant (NS) differences in resting Ca 2ϩ concentration were detected, but a significant difference in peak ⌬Indo-1 ratio was found (*P ϭ 0.017). C: averaged Indo-1 ratio responses from control (black traces; n ϭ 12) and mutant (gray traces; n ϭ 12) fibers elicited with a two-AP protocol with recovery periods of 40, 80, and 160 ms between stimuli. Traces were normalized to amplitude of the first stimulus to appreciate relative summation in mutant fibers. ajpcell.physiology.org twitch specific force (P 0 ) generated from a single action potential compared with WT controls. However, there was no difference in maximal tetanic P 0 generated between groups (Fig. 11D) . This resulted in a significantly increased tetanus-to-twitch P 0 ratio in mutant mice, an indicator of greater relative force summation with repetitive activity (Fig. 11E) . This is more clearly demonstrated in the normalized P 0 versus frequency of stimulation relationship depicted in Fig. 11B . At lower stimulation frequencies (10, 20, 40 Hz) , Ryr1 D/D mice demonstrated significantly less relative force; however, they showed greater relative summation at higher-frequency stimulation, which resulted in a similar maximal tetanic force response.
Next we sought to evaluate the maintenance of maximal force during prolonged repetitive fatiguing stimulation in Ryr1 ϩ/ϩ and Ryr1 D/D mice. The fatiguing paradigm and analysis were identical to that conducted previously in S100A1-knockout animals (24) . Briefly, fatiguing stimulation consisted of 200 ms, 100 Hz trains to elicit maximal tetanic force, with a train spaced every 2 s for 300 s. Force was recorded continuously for each of the 150 tetani over the time of stimulation, and the percent reduction of force between the first and last train (P 0,final Ϫ P 0,initial /P 0,final ) and the rate of force decline (fatigue tau) were calculated. No significant differences were seen in the rate of force decline or relative force decline between groups during fatiguing stimulation (Table 1) . A summary of the biometrics and force data from contractile force experiments is detailed in Table 1 . No significant differences were detected in body weight or muscle weight of the animals.
DISCUSSION
The present study describes a new mouse model for studying the in vivo regulation of RyR1 by CaM and S100A1. Previous studies with isolated membrane preparations and purified ryanodine receptors have suggested that CaM and S100A1 have a role in skeletal muscle EC coupling. However, the physiological significance of the regulation of RyR1 by these modulators remained unclear. Herein, we describe the creation and characterization of a genetically modified mouse with a single amino acid substitution in the CaM binding domain of RyR1 (RyR1-L3625D or RyR1 D ). The position of the L3625D mutation is in the S100A1/CaM binding domain of RyR1 on the hydrophobic face of an amphipathic helix (Fig. 4) . We previously expressed RyR1 D in HEK 293 cells and found that this single amino acid substitution was sufficient to inhibit CaM binding and regulation of the recombinant RyR1 mutant at submicromolar and micromolar Ca 2ϩ (50) . Similarly, the L3625D mutation abolished CaS100A1 binding to the S100A1/CaM binding domain of RyR1 (Fig. 4E) . Results of the present study suggest that the L3625D mutation impairs CaM and S100A1 regulation of RyR1 in skeletal muscle, and thereby alters adult skeletal muscle EC coupling and force generation. S100A1 has a significant role in skeletal muscle Ca 2ϩ homeostasis by primarily regulating RyR1-mediated SR Ca 2ϩ release (11) . In agreement with an earlier study (43) , S100A1 activated Ryr1 ϩ/ϩ at nanomolar but not micromolar Ca 2ϩ . Binding studies with fusion proteins revealed three S100A1 Values are means Ϯ SE. M, male; F, female; TA, tibialis anterior; P0, specific force. *P Ͻ 0.05. ϩ/ϩ channels were activated by 0.3 M S100A1, which is within the concentration range of S100A1 protein concentration in fast-twitch skeletal muscle (15, 52) . However, it will be important to establish in future studies the local concentrations of free S100A1 and CaM available to bind RyR1 at the triad junction, because these likely determine relative binding and competition at this site in vivo. S100A1 binds to the NH 2 -terminal region of the CaM binding domain involved in the binding of the Ca 2ϩ -bound form of CaM to RyR1 (17, 30) . The apparent discrepancy of binding to this region at submicromolar Ca 2ϩ concentrations can be explained by the fact that binding to RyR1 increases the Ca 2ϩ binding affinity of S100A1, as demonstrated for S100 family members in the presence of various target proteins (16, 46) . We suggest that at resting Ca 2ϩ concentrations, in agreement with binding (47, 50) and single-channel (Figs. 2 and 5 ) studies, RyR1 may be activated by S100A1 and CaM, whereas at elevated Ca 2ϩ concentrations, following a train of action potentials, CaM but not S100A1 inhibits RyR1.
The RyR1-L3625D mutant mice provided membrane fractions that contained the two key SR Ca 2ϩ transport systems, RyR1 and the ATP-dependent Ca 2ϩ pump. An impaired activation of RyR1 by S100A1 and CaM suggests that depressed Ca 2ϩ transients observed in mutant fibers in response to a voltage stimulus are in part due to expression of dysfunctional RyR1. Our data also support the idea that diminished mice. The combination of these two opposing effects may partially explain the lack of effect of this mutation during repetitive muscular activity in Ryr1 D/D mice. In contrast, muscles from S100A1 Ϫ/Ϫ animals showed decreased contractile force for a single action potential as well as decreased force during repetitive stimulation (24) , suggesting that S100A1 activation is required to maintain in vivo muscle performance. Comparison of the present results in RyR1-L3625D mice with those from S100A1 Ϫ/Ϫ animals provides some insight into the roles of S100A1 and CaM in skeletal muscle EC coupling. The 41% average decrease in peak SR Ca 2ϩ release flux during voltage-clamp depolarization of FDB fibers from Ryr1 D/D mice ( Fig. 10) was remarkably similar to the 42% average decrease in release flux seen in FDB fibers from S100A1 Ϫ/Ϫ mice under identical conditions (25, 26 (Figs. 7 and 8 ) and S100A1 Ϫ/Ϫ muscle fibers (27) . There is also a similar decrease in contractile twitch force between Ryr1 D/D (Fig. 11) and S100A1 Ϫ/Ϫ mice (24) . Considering that S100A1 primarily regulates RyR1 in skeletal muscle (11) , our findings suggest two important concepts. First, elimination of the S100A1 activating effects on RyR1 appears to fully account for the suppressed release flux and twitch force generation in Ryr1 D/D mutant mice. Second, suppressed Ca 2ϩ release in S100A1 Ϫ/Ϫ fibers is likely attributable to impaired S100A1 regulation of RyR1 specifically at the CaM binding site. Conversely, the decreased summation of Ca 2ϩ transients and force seen during repetitive stimulation in S100A1 Ϫ/Ϫ muscle may be attributed to the lack of competition of S100A1 with the inhibitory action of CaCaM at this same binding site on RyR1.
In contrast to a predominant role S100A1 may have in promoting channel activation from rest, a clear role for CaCaM regulation of release flux becomes evident as cytosolic [Ca 2ϩ ] increases in Ryr1 D/D mice during maintained fiber stimulation. In response to sustained depolarization, there was a shoulder of prolonged Ca 2ϩ release flux in Ryr1 D/D fibers. Importantly, this "shoulder" was markedly absent in S100A1-deficient fibers exposed to the same depolarizing step (25, 26) (Figs. 8 and 9 ). S100A1 Ϫ/Ϫ fibers demonstrate the opposite effects of reduced transient summation and greater inactivation of release flux during prolonged trains of action potentials (24) . This suggests that CaCaM may have an inhibitory role in S100A1 Ϫ/Ϫ fibers, due to the lack of regulation of RyR1 by endogenous S100A1.
The RyR1 CaM binding domain has a cysteine (Cys3635) that is S-nitrosylated by low, physiological concentrations (0.75 M) of nitric oxide (NO) (38) . Activation of RyR1 by NO was observed at PO 2 of ϳ10 mmHg (simulating muscle oxygen tension) in the presence but not absence of CaM (38) . This suggests that an impaired CaM binding renders Ryr1 D/D insensitive to NO activation. The effects of eliminating the interaction of CaM with the ryanodine receptors were previously examined in cardiac muscle. We generated a mutant mouse deficient in the regulation by CaM of the cardiac ryanodine receptor isoform (Ryr2 ADA/ADA mouse) (49) . Mice that expressed only the mutant form of RyR2 showed signs of cardiac hypertrophy as early as 1 day after birth and died ϳ2 wk later. Sustained Ca 2ϩ transients were observed in cultured homozygous cardiomyocytes isolated from 1-day-old mice. The results indicate that impaired CaM and likely S100A1 regulation of the ryanodine receptors has markedly different effects in cardiac and skeletal muscle. One possible explanation is that the two isoforms are differently regulated by CaM and S100A1. In contrast to Ryr2 ADA/ADA mice, S100A1
Ϫ/Ϫ mice have a normal lifespan and cardiac function under baseline conditions (6) , which suggests a predominant role of CaM regulation of RyR2 compared with S100A1 in cardiac muscle. In cardiac failure, S100A1 protein levels are decreased (28, 44) . Gene expression restored cardiac function in a rat model of heart failure (23), and transgenic overexpression in the heart increased myocardial performance (21) . Differences in the regulation between RyR1 and RyR2 may be also due to the expression and greater role in Ca 2ϩ signaling of RyR2 during early development. Mutant mice lacking RyR2 die at approximately embryonic day 10 (41), whereas mutant mice lacking a functional RyR1 are viable until birth (40) .
In cardiac muscle, S100A1 interacts with multiple targets including RyR2 and Ca 2ϩ -ATPase (SERCA2a) and its regulatory protein, phospholamban (11, 46) . S100A1 has been found to both inhibit and activate RyR2 (10, 45) and to bind to a peptide containing part of the conserved CaM binding site of RyR1 and RyR2 (47) . However, the interaction sites for S100A1 in the intact RyR2, and their potential loss in the Ryr2 ADA/ADA mutant mouse, remain to be determined. In summary, at nanomolar Ca 2ϩ concentrations CaM and S100A1 activate RyR1 in single-channel measurements. Regulation involves a shared binding site in RyR1. On the other hand, only CaM inhibits RyR1 at micromolar Ca 2ϩ concentrations. CaM and S100A1 regulation tunes SR Ca 2ϩ release to differentially regulate EC coupling during high-and lowfrequency stimulation. However, how CaM and S100A1 compete for the site under physiological and pathological conditions in skeletal muscle and other tissues to regulate Ca 2ϩ release from intracellular Ca 2ϩ stores requires further investigation. 
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